Organidin Patient, Information, Instructions - Guaifenesin (oral)

Organidin Patient, Information, Instructions - Guaifenesin (oral)

PATIENT INFORMATION

TUSSI-ORGANIDIN® NR* (* Newly Reformulated): Patients should be warned about engaging in activities requiring mental alertness, such as driving a car or operating dangerous machinery. Take as prescribed; do not exceed prescribed dose or frequency. Do not crush or chew extended release tablet. Maintain adequate hydration (2-3l L/d of fluids) unless instructed to restrict fluid intake.

TUSSI-ORGANIDIN® DM NR* (* Newly Reformulated): Patients should be warned not to use this product if they are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the M.O. drug. If patients are uncertain whether a prescription drug contains an MAOI, they should be instructed to consult a health professional before taking such a product.